Location
Cambridge, MA
Compensation
$48k–$71k USD
Type
intern
Posted
Yesterday
Market range · function + seniority
p25 · target · p75 · n=800
Posted $71k · well below market
Tailor your résumé to this role in 30 seconds.
Free account · ATS keyword check · per-job bullet rewrite by Claude.
Company Overview:
Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
Position Overview:
Beam is seeking a highly motivated co-op student to join the Biotherapeutics Discovery Team, from January through June 2027. The individual will be responsible for screening, characterizing, and optimizing therapeutic antibodies using cell biology, molecular biology, and biochemistry techniques to support biotherapeutic drug discovery programs at Beam. The position will play a key role in advancing new programs from discovery toward the clinic in a highly collaborative and fast-paced environment.
Responsibilities:
Qualifications:
Hourly pay will will be determined based on several factors, including but not limited to, relevant experience, skills, and education.
More open roles at Beam Therapeutics
Hiring velocity, headcount trend, and every open posting on one page.
Open postings ranked by description similarity — useful if this role isn't quite right.